Catalyst Wire Dossier Catalyst Wire Dossier

PN20

· Chongqing Peg-Bio Biopharm Co., Ltd.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PN20, covering 2025-03-13 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure [Phase 1, Phase 2]

See pricing